These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12626445)

  • 1. Simple method to distinguish between primary and secondary C3 deficiencies.
    Pereira de Carvalho Florido M; Ferreira de Paula P; Isaac L
    Clin Diagn Lab Immunol; 2003 Mar; 10(2):216-20. PubMed ID: 12626445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inherited deficiency of the third component of complement, C3, in guinea pigs.
    Burger R; Gordon J; Stevenson G; Ramadori G; Zanker B; Hadding U; Bitter-Suermann D
    Eur J Immunol; 1986 Jan; 16(1):7-11. PubMed ID: 3512275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for deficiencies in the classical and alternative pathways of complement by hemolysis in gel.
    Truedsson L; Sjöholm AG; Laurell AB
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):161-6. PubMed ID: 7032205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of an R3 reagent (serum depleted of the third component of human complement (C3)) by immunoadsorption. Application to the hemolytic assay of human C3.
    Fontaine M; Joisel F; Dumouchel L
    J Immunol Methods; 1980; 33(2):145-58. PubMed ID: 6989915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic plate assay for quantification of active human complement component C3 using methylamine-treated plasma as complement source.
    Ploug M; Jessen TE; Welinder KG; Barkholt V
    Anal Biochem; 1985 May; 146(2):411-7. PubMed ID: 3927773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H.
    S Reis E; Falcão DA; Isaac L
    Scand J Immunol; 2006 Mar; 63(3):155-68. PubMed ID: 16499568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel assay for serum complement activity: C42 generation assay.
    Kobayashi E; Kitano E; Kitamura H
    Int Arch Allergy Immunol; 1999 Sep; 120(1):71-7. PubMed ID: 10529591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement component deficiencies and infection: C5, C8 and C3 deficiencies in three families.
    Sanal O; Loos M; Ersoy F; Kanra G; Seçmeer G; Tezcan I
    Eur J Pediatr; 1992 Sep; 151(9):676-9. PubMed ID: 1396929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum factors activating the alternative complement pathway in autoimmune disease: description of two different factors from patients with systemic lupus erythematosus.
    Arroyave CM; Wilson MR; Tan EM
    J Immunol; 1976 Mar; 116(3):821-6. PubMed ID: 815434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total hemolytic complement (CH50) and its fractions C3 and C4 in the sera of patients with localized juvenile periodontitis.
    Anil S; Beena VT; Remani P; Mysore J; Vijayakumar T
    Ann Dent; 1993; 52(1):18-20. PubMed ID: 8323245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolysis of normal human erythrocytes by autologous serum complement.
    Kitamura H; Nagano A; Kitano E
    Int Arch Allergy Immunol; 1993; 100(3):209-14. PubMed ID: 8453307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A congenital deficiency of the C3 fraction of complement. A familial study].
    Sassi F; Bejaoui M; Ayed K
    Tunis Med; 2003 May; 81(5):354-8. PubMed ID: 12934459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and purification of C3 from human plasma.
    O'Rear LD; Ross GD
    Curr Protoc Immunol; 2001 May; Chapter 13():13.3.1-13.3.16. PubMed ID: 18432716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement C3 deficiency: human, animal, and experimental models.
    Singer L; Colten HR; Wetsel RA
    Pathobiology; 1994; 62(1):14-28. PubMed ID: 8031472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation in semisolid media: insolubilization of alternative pathway convertases in agar gels with C3 nephritic factor-containing sera.
    Arnaout MA; Davis AE; Rosen RS; Alper CA
    J Immunol; 1977 Oct; 119(4):1316-20. PubMed ID: 894039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis.
    Alper CA; Colten HR; Gear JS; Rabson AR; Rosen FS
    J Clin Invest; 1976 Jan; 57(1):222-9. PubMed ID: 1107355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of serum or buffer-changed EDTA-plasma in a rapid, inexpensive, and easy-to-perform hemolytic complement assay for differential diagnosis of systemic lupus erythematosus and monitoring of patients with the disease.
    Ekdahl KN; Norberg D; Bengtsson AA; Sturfelt G; Nilsson UR; Nilsson B
    Clin Vaccine Immunol; 2007 May; 14(5):549-55. PubMed ID: 17344343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hemolytic method for the measurement of nephritic factor.
    West CD
    J Immunol Methods; 2008 Jun; 335(1-2):1-7. PubMed ID: 18410942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
    Whaley K; Schur PH; Ruddy S
    J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.